Skip to main content

Breadcrumb

  1. Home

Claims Data

Valid for Measure Submission

Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis

  • Percentage of surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients, who had an order for Low Molecular Weight Heparin (LMWH), Low-Dose Unfractionated Heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time

    CBE ID
    0239

Perioperative Hemorrhage or Hematoma Rate (PSI 09)

  • Perioperative hemorrhage or hematoma cases involving a procedure to treat the hemorrhage or hematoma, following surgery per 1,000 surgical discharges for patients ages 18 years and older. Excludes cases with a diagnosis of coagulation disorder; cases with a principal diagnosis of perioperative hemorrhage or hematoma; cases with a secondary diagnosis of perioperative hemorrhage or hematoma present on admission; cases where the only operating room procedure is for treatment of perioperative hemorrhage or hematoma; obstetric cases.

    CBE ID
    2909

Perioperative Temperature Management

  • Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time

    CBE ID
    0454

Persistence of Beta-Blocker Treatment After a Heart Attack

  • The percentage of patient’s 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who received persistent beta-blocker treatment for six months after discharge.

    CBE ID
    0071

Pharmacotherapy Management of COPD Exacerbation

  • This measure assesses the percentage of COPD exacerbations for patients 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1-November 30 of the measurement year and who were dispensed appropriate medications. Two rates are reported:
    1. Dispensed a systemic corticosteroid (or there was evidence of an active prescription) within 14 days of the event.
    2. Dispensed a bronchodilator (or there was evidence of an active prescription) within 30 days of the event.

    CBE ID
    2856